Alert: Rating Downgrade (10/11/24)-GSK plc (NYSE: GSK).

out_logo_500#08463.jpg

Stock Rating Downgrade

Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for GSK plc (NYSE: GSK) fell significantly during the last several trading days. GSK’s current Value Trend Rating is F and the prior Rating was C. Details supporting this lower rating are included in our next report.

out_mm#08463.jpg

Recent Price Action

GSK plc (NYSE: GSK) stock declined slightly by -1.0% on 10/11/24. The stock closed at $38.83. Moreover, this decline was accompanied by unusually high trading volume at 171% of normal. The stock has performed in line with the market over the last nine months and has risen 1.2% during the last week.

Current PriceTarget Research Rating

GSK’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.

GSK plc has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. GSK plc has a slightly negative Power Rating of 32 and a poor Appreciation Score of 19, triggering the Lowest Value Trend Rating.

Be the first to comment

Leave a Reply

Your email address will not be published.


*